Stifel analyst Daniel Arias lowered the firm’s price target on Illumina (ILMN) to $135 from $160 and keeps a Buy rating on the shares. Illumina posted a “nice” Q1 beat and then reduced the FY25 guidance, as expected, the analyst tells investors. The cut to the top-line “was maybe a point or so deeper than we thought it might be,” but the EPS outlook is better than the firm anticipated thanks to strong mitigation activities, the analyst added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target raised to $89 from $86 at TD Cowen
- Illumina price target lowered to $85 from $120 at JPMorgan
- Illumina price target lowered to $114 from $122 at Guggenheim
- Illumina’s Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges
- Illumina Reports Q1 2025 Financial Results Amid Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue